These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 10788680)

  • 41. Pharmacokinetic interactions of clozapine with selective serotonin reuptake inhibitors: differential effects of fluvoxamine and paroxetine in a prospective study.
    Wetzel H; Anghelescu I; Szegedi A; Wiesner J; Weigmann H; Härter S; Hiemke C
    J Clin Psychopharmacol; 1998 Feb; 18(1):2-9. PubMed ID: 9472836
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Influence of postmenopausal hormone replacement therapy on platelet serotonin uptake site and serotonin 2A receptor binding.
    Wihlbäck AC; Sundström-Poromaa I; Allard P; Mjörndal T; Spigset O; Bäckström T
    Obstet Gynecol; 2001 Sep; 98(3):450-7. PubMed ID: 11530128
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [SSRI antidepressants and negative schizophrenic symptoms: differences between paroxetine and fluvoxamine in patients treated with olanzapine].
    Rusconi AC; Carlone C; Muscillo M; Coccanari de' Fornari MA; Podda L; Piccione M
    Riv Psichiatr; 2009; 44(5):313-9. PubMed ID: 20066819
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inverse relationship between numbers of 5-HT transporter binding sites and life history of aggression and intermittent explosive disorder.
    Coccaro EF; Lee R; Kavoussi RJ
    J Psychiatr Res; 2010 Feb; 44(3):137-42. PubMed ID: 19767013
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ethanol intake and 3H-serotonin uptake. II: A study in alcoholic patients using platelets 3H-paroxetine binding.
    Daoust M; Lhuintre JP; Ernouf D; Legrand E; Breton P; Boucly P
    Life Sci; 1991; 48(20):1977-83. PubMed ID: 1827171
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparative study of platelet 3H-paroxetine and 3H-imipramine binding in panic disorder patients and healthy controls.
    Faludi G; Tekes K; Tóthfalusi L
    J Psychiatry Neurosci; 1994 Mar; 19(2):109-13. PubMed ID: 8204562
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Binding of [3H]paroxetine to platelets of depressed patients: seasonal differences and effects of diagnostic classification.
    D'Hondt P; Maes M; Leysen JE; Gommeren W; Scharpé S; Cosyns P
    J Affect Disord; 1994 Sep; 32(1):27-35. PubMed ID: 7798464
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Differences in platelet serotonin transporter sites between African-American tobacco smokers and non-smokers.
    Patkar AA; Gopalakrishnan R; Berrettini WH; Weinstein SP; Vergare MJ; Leone FT
    Psychopharmacology (Berl); 2003 Mar; 166(3):221-7. PubMed ID: 12589524
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Serotonin transporter characteristics in lymphocytes and platelets of male aggressive schizophrenia patients compared to non-aggressive schizophrenia patients.
    Barkan T; Peled A; Modai I; Barak P; Weizman A; Rehavi M
    Eur Neuropsychopharmacol; 2006 Dec; 16(8):572-9. PubMed ID: 16713194
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Association of [3H]-imipramine and [3H]-paroxetine binding with the 5HT transporter in brain and platelets: relevance to studies in depression.
    Langer SZ; Galzin AM; Poirier MF; Loo H; Sechter D; Zarifian E
    J Recept Res; 1987; 7(1-4):499-521. PubMed ID: 3040983
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of chronic paroxetine administration on measures of aggressive and impulsive responses of adult males with a history of conduct disorder.
    Cherek DR; Lane SD; Pietras CJ; Steinberg JL
    Psychopharmacology (Berl); 2002 Jan; 159(3):266-74. PubMed ID: 11862359
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Alteration of serotonin transporter density and activity in fibromyalgia.
    Bazzichi L; Giannaccini G; Betti L; Mascia G; Fabbrini L; Italiani P; De Feo F; Giuliano T; Giacomelli C; Rossi A; Lucacchini A; Bombardieri S
    Arthritis Res Ther; 2006; 8(4):R99. PubMed ID: 16790074
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Platelet serotonin and [3H]paroxetine binding correlate with recurrence of suicidal behavior.
    Verkes RJ; Fekkes D; Zwinderman AH; Hengeveld MW; Van der Mast RC; Tuyl JP; Kerkhof AJ; Van Kempen GM
    Psychopharmacology (Berl); 1997 Jul; 132(1):89-94. PubMed ID: 9272764
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of serotonin reuptake inhibitors on aggressive behavior in psychiatrically hospitalized adolescents: results of an open trial.
    Constantino JN; Liberman M; Kincaid M
    J Child Adolesc Psychopharmacol; 1997; 7(1):31-44. PubMed ID: 9192540
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Variations in [3H]imipramine and 5-HT2A but not [3H]paroxetine binding sites in suicide brains.
    Rosel P; Arranz B; Vallejo J; Oros M; Crespo JM; Menchon JM; Navarro MA
    Psychiatry Res; 1998 Jun; 82(3):161-70. PubMed ID: 9754440
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Enhanced displacement of [3H]imipramine, but not [3H]paroxetine binding by plasma from depressed patients.
    Lawrence KM; Lowther S; Falkowski J; Jacobson RR; Horton RW
    J Affect Disord; 1997 Nov; 46(2):127-34. PubMed ID: 9479616
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clozapine and paroxetine in the treatment of schizophrenia with obsessive-compulsive features.
    Strous RD; Patel JK; Zimmet S; Green AI
    Am J Psychiatry; 1999 Jun; 156(6):973-4. PubMed ID: 10360153
    [No Abstract]   [Full Text] [Related]  

  • 58. Platelet serotonin measures in primary dysthymia.
    Ravindran AV; Chudzik J; Bialik RJ; Lapierre YD; Hrdina PD
    Am J Psychiatry; 1994 Sep; 151(9):1369-71. PubMed ID: 8067494
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Platelet serotonin uptake and paroxetine binding among allelic genotypes of the serotonin transporter in alcoholics.
    Javors MA; Seneviratne C; Roache JD; Ait-Daoud N; Bergeson SE; Walss-Bass MC; Akhtar FZ; Johnson BA
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):7-13. PubMed ID: 15610939
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Paroxetine, a selective serotonin reuptake inhibitor, reduces depressive symptoms and subjective handicaps in patients with dizziness.
    Horii A; Mitani K; Kitahara T; Uno A; Takeda N; Kubo T
    Otol Neurotol; 2004 Jul; 25(4):536-43. PubMed ID: 15241233
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.